Author:
Scognamiglio Paola,Chiaradia Giacomina,De Carli Gabriella,Giuliani Massimo,Mastroianni Claudio Maria,Aviani Barbacci Stefano,Buonomini Anna Rita,Grisetti Susanna,Sampaolesi Alessandro,Corpolongo Angela,Orchi Nicoletta,Puro Vincenzo,Ippolito Giuseppe,Girardi Enrico,
Abstract
Abstract
Background
The aim of our work was to evaluate the potential impact of the European policy of testing for HIV all individuals presenting with an indicator disease, to prevent late diagnosis of HIV. We report on a retrospective analysis among individuals diagnosed with HIV to assess whether a history of certain diseases prior to HIV diagnosis was associated with the chance of presenting late for care, and to estimate the proportion of individuals presenting late who could have been diagnosed earlier if tested when the indicator disease was diagnosed.
Methods
We studied a large cohort of individuals newly diagnosed with HIV infection in 13 counselling and testing sites in the Lazio Region, Italy (01/01/2004-30/04/2009). Considered indicator diseases were: viral hepatitis infection (HBV/HCV), sexually transmitted infections, seborrhoeic dermatitis and tuberculosis. Logistic regression analysis was performed to estimate association of occurrence of at least one indicator disease with late HIV diagnosis.
Results
In our analysis, the prevalence of late HIV diagnosis was 51.3% (890/1735). Individuals reporting at least one indicator disease before HIV diagnosis (29% of the study population) had a lower risk of late diagnosis (OR = 0.7; 95%CI: 0.5-0.8) compared to those who did not report a previous indicator disease. 52/890 (5.8%) late presenters were probably already infected at the time the indicator disease was diagnosed, a median of 22.6 months before HIV diagnosis.
Conclusions
Our data suggest that testing for HIV following diagnosis of an indicator disease significantly decreases the probability of late HIV diagnosis. Moreover, for 5.5% of late HIV presenters, diagnosis could have been anticipated if they had been tested when an HIV indicator disease was diagnosed.
However, this strategy for enhancing early HIV diagnosis needs to be complemented by client-centred interventions that aim to increase awareness in people who do not perceive themselves as being at risk for HIV.
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Antiretroviral Therapy Cohort Collaboration: Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008, 372: 293-299.
2. Hamers FF, Phillips AN: Diagnosed and undiagnosed HIV-infected populations in Europe. HIV Med. 2008, 9 (Suppl 2): 6-12.
3. Johnson M, Sabin C, Girardi E: Definition and epidemiology of late presentation in Europe. Antivir Ther. 2010, 15 (Suppl 1): 3-8. 10.3851/IMP1522.
4. Likatavicius G, Van de Laar MJ: HIV and AIDS in the European Union, 2009. Euro Surveill. 2010, 15 (48): 19737-
5. Centers for Disease Control and Prevention (CDC): Persons tested for HIV–United States, 2006. MMWR Morb Mortal Wkly Rep. 2008, 57: 845-849.
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献